The Emirates Drug Establishment (EDE) highlighted the UAE’s strategic advantages for pharmaceutical companies, emphasizing its advanced logistics infrastructure, transparent regulatory environment, and investor-friendly policies. The announcement followed discussions aimed at strengthening international partnerships and expanding opportunities for pharmaceutical innovation, trade, and market access.

Key highlights:

  • UAE representatives conducted engagements with pharmaceutical stakeholders in New Zealand to strengthen bilateral cooperation in healthcare and pharmaceuticals
  • Discussions included leading pharmaceutical companies such as AFT Pharmaceuticals and Douglas Pharmaceuticals, exploring collaboration and investment opportunities
  • The UAE continues to position itself as a regional pharmaceutical hub, offering access to markets across the Middle East, Africa, and South Asia
  • Advanced logistics capabilities, including world-class ports, air connectivity, and supply chain infrastructure, support efficient pharmaceutical distribution
  • Comprehensive Economic Partnership Agreements (CEPAs) continue to facilitate international trade and cross-border business expansion
  • The regulatory framework provides transparency, predictability, and investor-friendly approaches to pharmaceutical pricing and market access
  • The UAE is experiencing continued growth in pharmaceutical research and development activities, supporting innovation across the healthcare sector
  • Multinational pharmaceutical companies are increasingly establishing regional operations and headquarters within the UAE
  • Discussions highlighted opportunities in innovative medicines, rare disease treatments, and advanced therapeutic technologies
  • Stakeholders explored strategic partnerships, investment opportunities, and avenues for strengthening international pharmaceutical collaboration
  • Streamlined drug registration processes and regulatory transparency were identified as key enablers for market entry and expansion
  • The initiative supports the UAE’s broader vision of becoming a leading regional center for pharmaceutical innovation, manufacturing, and commercialization

This development reinforces the UAE’s growing attractiveness as a strategic destination for pharmaceutical investment, regulatory expansion, and regional market access initiatives.

Consult Now

Source
https://www.ede.gov.ae/ar/w/al-hajeri-uae-combines-advanced-logistics-infrastru…
Select Mandate HA
EDE
Select Mandate Function
Regulatory Affairs